Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
04/2004
04/15/2004WO2001061036A8 A method of mapping restriction endonuclease cleavage sites
04/15/2004US20040073956 Assay techniques based on growth stage dependent expression inc. elegans
04/15/2004US20040073378 Mutational profiles in hiv-1 reverse transcriptase correlated with phenotypic drug resistance
04/15/2004US20040073377 Methods and compositions for regulating bone and cartilage formation
04/15/2004US20040073021 Cloning and sequencing of the porcine interleukin-12 receptor beta-1 and beta-2 chains
04/15/2004US20040073020 Novel human phosphodiesterase IV isozymes
04/15/2004US20040073019 Comprise nucleotide sequences coding hydrolase associated with degradation of cyclic nucleotides for identifying modulators of defects in signal transduction
04/15/2004US20040073018 Comprises nucleotide seuences coding enzyme which catalyzes methylation of homocysteine to methionine for diagnosis and treatment of hyperhomocysteinemia, nervous system, and cell proliferative disorders
04/15/2004US20040073017 Surface modification, linker attachment, and polymerization methods
04/15/2004US20040073016 Compositions and methods for the therapy and diagnosis of breast cancer
04/15/2004US20040073004 Comprises Ajuba like protein for diagnosis, prevention and treatment of cell proliferative, cardiovascular and neurodegenerative disease
04/15/2004US20040073003 Neuromedin u delta
04/15/2004US20040072999 Novel protein inhibitor of apoptosis proteins
04/15/2004US20040072998 Comprises nucleotide sequences coding transient receptor proteins (TRP) for diagnosis, prevention and treatment of cell proliferative disorders; antitumor agents
04/15/2004US20040072997 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
04/15/2004US20040072993 Identifying modulator of chimeric chaperone protein for treatment and diagnosis of immune, cell proliferative and infectious disorders
04/15/2004US20040072877 Using desaturase inhibitor; antidiabetic agents
04/15/2004US20040072780 Methods for obtaining inhibitors of tirc7 ligand binding and uses thereof
04/15/2004US20040072773 Novel functions for dp214
04/15/2004US20040072772 Survival Regulating Kinase, SRK, involved in cell signal transduction; method of detecting a protein kinase activity in a human SRK polypeptide
04/15/2004US20040072769 Methods for design and selection of short double-stranded oligonucleotides, and compounds of gene drugs
04/15/2004US20040072759 Polypeptides
04/15/2004US20040072747 Novel member of the epha receptor family
04/15/2004US20040072739 Compositions and methods for regulating endogenous inhibitor of ATP synthase, including treatment for diabetes
04/15/2004US20040072722 Assessing both the ability of a chemotherapeutic to destroy cells and the genetic propensity of those cells for resistance, results obtained by using above methods provide insight into in vivo effectiveness of a chemothereupic drug
04/15/2004US20040072372 Preparing spatially encoded planar assemblies of particles formed on substrate by sequential injection of a multiplicity of groups onto interfaces formed by an electrolyte-insulator-semiconductor (EIS)
04/15/2004US20040072329 Propagating culture of plant yeast for malt evaluation; alcoholic beverages and flavoring; quality control
04/15/2004US20040072305 Preparing CDNA sequences from RNA sequences extracted from formalin-fixed and optionally paraffin-embedded (FFPE) cells for diagnosing breast cancer
04/15/2004US20040072297 Comprises maternal protein (MATER) for treatment of infertility and reduced fertility; contraceptives
04/15/2004US20040072286 Comprises nucleotide sequences coding synovium/cartilage inflammation-linked messenger 1 (SCIM-1) for diagnosis and treatment of rhematoid arthritis
04/15/2004US20040072281 Fixed tumor, nerve, glial, muscle and blood cells; microscopic tissue fixation and disease diagnosis
04/15/2004US20040072280 Assays for trichomonal and other hydrolases
04/15/2004US20040072279 Culture medium for detecting bacteria of listeria genus
04/15/2004US20040072277 Equilibrating biosensor for amperometric determination of creatinine in biological liquids
04/15/2004US20040072276 Preparing enzymatic polypeptide with target substrate specificities for use in medical diagnostics, textile treatment and papermaking
04/15/2004US20040072275 Interaction of NMDA receptor with protein tyrosine phosphatase
04/15/2004US20040072270 Cell-based fluorescence resonance energy transfer (FRET) assays for clostridial toxins
04/15/2004US20040072268 Methods for regulating BRCA1-BRCA2-containing complex activity
04/15/2004US20040072265 Using tumor antigen CDNA probes to diagnose and treat brain disorders; antiproliferative/antitumor agents
04/15/2004US20040072264 Comprises nucleotide sequences coding ca protein (CAP) for diagnosing and treating cell proliferative disorders; antiproliferative agents
04/15/2004US20040072263 Handheld apparatus for diagnosing cancer via presence tumor marker proteins
04/15/2004US20040072257 Identifying a protein complex produced in vivo and regulated by nitric oxide whose formation is inhibited by a redox state modifier molecule (RSMM); hybrids characteristic of a pathophysiological process; implicated in apoptotic signaling
04/15/2004US20040072255 Isolated post-translationally modified mammalian proteins for monitoring and diagnosing muscle damage
04/15/2004US20040072252 Heteroaryl substituted benzothiazole dioxetanes
04/15/2004US20040072247 Detection method
04/15/2004US20040072242 Determining total microbial content in sample via amplification of ribosomal DNA; bioremediation; biodegradation; diagnosing bacterial infections
04/15/2004US20040072239 Method for controlling the microbiological quality of an aqueous medium and kit therefor
04/15/2004US20040072237 Diagnosing inflammatory syndromes in mammals via monitoring altered gene expression patterns of endothelial growth factor, interleukins and/or tumor necrosis factor receptors
04/15/2004US20040072235 Cytochrome P450 genetic variations
04/15/2004US20040072234 High affinity nucleic acid ligands to lectins
04/15/2004US20040072233 Multihue labels
04/15/2004US20040072231 Nanoparticles having oligonucleotides attached thereto and uses therefor
04/15/2004US20040072230 Human SORBS1 genetic variations contribute to insulin resistance, obesity, type 2 diabetes, and hypertension
04/15/2004US20040072226 Movement of multi-enzymatic nanoassemblies on recognition landscapes
04/15/2004US20040072223 Using matrix immobilized nanoparticles to detect proteins and/or nucleic acids
04/15/2004US20040072221 Process for the isolation of the extrachromosomal dna and method for the diagnosis based on the electrophoretic analysis of such dna
04/15/2004US20040072220 Neurotonin and use thereof
04/15/2004US20040072218 Methods and kits for identifying scavengers of reactive oxygen species (ros)
04/15/2004US20040072217 Identifying allelic variation in restriction fragment length polymorphisms
04/15/2004US20040072215 Solid-phase nucleic acid isolation
04/15/2004US20040072213 Compositions for DNA amplification, synthesis, and mutagenesis
04/15/2004US20040072212 Providing a reagent containing a ligand including a recognition element and a reactive component, and the reagent is capable of reversible, intramolecular attachment between ligand and reactive component, binding the reagent with target
04/15/2004US20040072210 Reagents and methods useful for detecting diseases of the breast
04/15/2004US20040072209 Methods of labelling polynucleotides with dibenzorhodamine dyes
04/15/2004US20040072208 Surface acoustic wave sensors and method for detecting target analytes
04/15/2004US20040072206 Screening for enzyme inhibitor to prevent microorganismal propagation; bactericides; antibiotic
04/15/2004US20040072203 After extension of the primer using a polymerase, primer-extension product is complexed with a solid support to which is attached an arylboronic acid complexing group, separation of resulting complex from reaction mixture
04/15/2004US20040072202 Incorporating a base selected from the group consisting of 7-deazaguanosine, 2-aminopurine, 8-aza-7-deazaguanosine, 1H-purine, and hypoxanthine into the oligonuclotide of the oligonuleotide array
04/15/2004US20040072201 Methods of identifying compounds that inhibit nonstop degradation of mRNA
04/15/2004US20040072200 Detection of nucleic acid polymorphisms
04/15/2004US20040072199 Method for marking samples containing dna by means of oligonucleotides
04/15/2004US20040072198 Diagnosis of diseases associated with cdk4
04/15/2004US20040072197 Assay for the detection and quantitation of hemimethylation
04/15/2004US20040072195 Single-tube, ready-to-use assay kits, and methods using same
04/15/2004US20040072193 Detecting gene expression in cells, comprising trapping cell on filter or membrane, contacting cell with membrane permeation solution, dissolving membrane, recovering and analyzing messenger RNA using oligonuclelotide column
04/15/2004US20040072192 Cancer-linked genes as targets for chemotherapy
04/15/2004US20040072191 Antisense RNA standardizing control
04/15/2004US20040072190 Hydrolases
04/15/2004US20040072188 Comprises nucleotide sequences coding B-cell activating factor receptor (BAFF-R) for diagnosis, prevention, treatment and/or delay of cancers, lymphomas and autoimmune diseases
04/15/2004US20040072184 Cancer associated protein kinases and their uses
04/15/2004US20040072182 Methods and compositions for detecting target sequences
04/15/2004US20040072181 Using transcriptional expression to monitor cellular response to steroids
04/15/2004US20040072177 Novel human serine-threonine kinase
04/15/2004US20040072176 Used to detect the presence of a target nucleic acid in a sample solution, eg to identify whether a patient is infected with a disease causing microorganism such as Chlamydia trachomatis
04/15/2004US20040072174 Calpain protease 12
04/15/2004US20040072172 Comprises enzymatic polypeptide associated with calcium dependent movement of phospholipids through plasmid membranes for diagnosis and treatment of thrombosis, angina pectoris and stroke; gene therapy
04/15/2004US20040072171 Screening for regulatory factors of neurofibromatosis (NF2); antitumor agents
04/15/2004US20040072170 Using creatine kinase messenger RNA expression profiles to diagnose congestive heart failure
04/15/2004US20040072169 Comprises nucleotide sequences coding polypeptide for exogenous expression in avian embryonic stem cells; bioreactors
04/15/2004US20040072167 A dry composition comprising a nucleotide linked to a fluorescent dye ;a method of making the composition comprising drying the composition
04/15/2004US20040072166 Using hepatoma up-regulated protein (HURP) gene expression as non-invasive screening of urogenital and tumors disorders
04/15/2004US20040072164 Using nested oligonucleotide to propagate preferential nucleic acids for detection, identification, quantification and analysis of mutant genotypes; drug resistance; pharmacogenomics
04/15/2004US20040072161 Haplotypes of the F2RL1 gene
04/15/2004US20040072160 Molecular toxicology modeling
04/15/2004US20040072159 Bzip type transcription factors regulating the expression of rice storage protein
04/15/2004US20040072158 Electrochemical detection of nucleic acid sequences
04/15/2004US20040072156 Detecting allelic variation in nuceotide sequences for use in rational drug design and screening; gene therapy and diseases diagnosis
04/15/2004US20040072155 Molecular methods for detecting guar gum additions to locust bean gum
04/15/2004US20040072154 Novel compositions and methods for cancer
04/15/2004US20040072152 Screening blood and identifying immunologically active antigen of herpes simplex virus (HSV) which attacks skin; diagnosing viral infection; viricides